(Q26237364)

English

Acute effects of COREXIT® EC9500A on cardiovascular function

abstract published in 2011

In more languages

default for all languages

No label defined

No description defined

edit

Statements

1 reference

19 July 2017

Acute effects of COREXIT® EC9500A on cardiovascular function (English)

1 reference

12 July 2017

NIOSH Health Effects Laboratory Division

object named as

HELD

1 reference

25 September 2023

2 references

19 July 2017

29 March 2020

2 references

19 July 2017

29 March 2020

2 references

19 July 2017

29 March 2020

1-(2-butoxy-1-methylethoxy)propan-2-ol

2 references

19 July 2017

29 March 2020

2 references

19 July 2017

29 March 2020

hydrotreated kerosene

2 references

19 July 2017

29 March 2020

1 reference

29 March 2020

cardiovascular disease

1 reference

29 March 2020

6

0 references

David G. Frazer

series ordinal

5

object named as

Frazer-D

1 reference

3

Roberts-JR

1 reference

4

Goldsmith-WT

1 reference

Krajnak-K

1

1 reference

Kan-H

2

1 reference

stated in

NIOSHTIC-2

language of work or name

English

1 reference

based on heuristic

inferred from title

process of elimination

publication date

10 April 2011

1 reference

stated in

NIOSHTIC-2

full work available at URL

https://www.fasebj.org/doi/10.1096/fasebj.25.1_supplement.1016.2

2 references

29 March 2020

1 January 2024

1 reference

25

1 reference

stated in

NIOSHTIC-2

issue

Meeting Abstracts

1 reference

stated in

NIOSHTIC-2

page(s)

1016.2

1 reference

stated in

NIOSHTIC-2

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

Identifiers

DOI

10.1096/FASEBJ.25.1_SUPPLEMENT.1016.2

1 reference

0 references

(Q26237364)

Acute effects of COREXIT® EC9500A on cardiovascular function

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)